PharmTech LCGC Sciex Webinar 11.10
|Articles|March 1, 2007

Agilent Technologies and Groton Biosystems sign agreement

Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) recently announced an agreement.

Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) recently announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.
PAT is a system for designing, analyzing, and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality.
The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments.The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' strong online sampling products and services.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.